Compounds > n-(3-(aminomethyl)benzyl)acetamidine

n-(3-(aminomethyl)benzyl)acetamidine and glutamic acid

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with glutamic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alborch, E; Burguete, MC; Castillo, J; Hurtado, O; Knowles, RG; Leza, JC; Lizasoain, I; Lorenzo, P; Moro, MA; Pérez-Asensio, FJ; Salom, JB; Torregrosa, G	1

Other Studies

1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and glutamic acid

Article	Year
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Neurobiology of disease, 2005, Volume: 18, Issue:2 Topics: Adenosine Triphosphate; Amidines; Amino Acid Transport System X-AG; Animals; Benzylamines; Brain; Cerebral Infarction; Cytoprotection; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Glutamic Acid; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Stroke; Treatment Outcome	2005

Article

Year

Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.

Neurobiology of disease, 2005, Volume: 18, Issue:2

Topics: Adenosine Triphosphate; Amidines; Amino Acid Transport System X-AG; Animals; Benzylamines; Brain; Cerebral Infarction; Cytoprotection; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Glutamic Acid; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Stroke; Treatment Outcome

2005